These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26116953)

  • 1. Treatment of adult hyper-IgD syndrome with canakinumab.
    Curtis CD; Fox CC
    J Allergy Clin Immunol Pract; 2015; 3(5):817-8. PubMed ID: 26116953
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyper-IgD syndrome in a patient with IgA immunodeficiency.
    Smerla RG; Agrafiotou C; Fragoulis GE
    Clin Exp Rheumatol; 2018; 36(5):934. PubMed ID: 30148429
    [No Abstract]   [Full Text] [Related]  

  • 3. Mevalonate kinase deficiency (hyper IgD syndrome with periodic fever)--different faces with separate treatments: two cases and review of the literature.
    Gençpınar P; Makay BB; Gattorno M; Caroli F; Ünsal E
    Turk J Pediatr; 2012; 54(6):641-4. PubMed ID: 23692791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome.
    van der Meer JW; Simon A
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii23-ii29. PubMed ID: 27856657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mevalonate kinase deficiency, a metabolic autoinflammatory disease.
    van der Burgh R; Ter Haar NM; Boes ML; Frenkel J
    Clin Immunol; 2013 Jun; 147(3):197-206. PubMed ID: 23110805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mevalonate kinase deficiency (hyper-IgD syndrome) overlap mutation familial Mediterranean fever.
    Flores Robles BJ; Peiró Callizo ME; Sanabria Sanchinel AA; Fernández Díaz C
    Reumatol Clin; 2017; 13(1):57. PubMed ID: 27079959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mevalonate kinase deficiency in 2016].
    Galeotti C; Georgin-Lavialle S; Sarrabay G; Touitou I; Koné-Paut I
    Rev Med Interne; 2018 Apr; 39(4):265-270. PubMed ID: 27659743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperimmunoglobulin D syndrome in an Indian family undiagnosed for 11 years.
    Abdulla MC; Hawkins PN; Alungal J; Rowczenio D
    Int J Rheum Dis; 2017 Dec; 20(12):2236-2237. PubMed ID: 26620804
    [No Abstract]   [Full Text] [Related]  

  • 9. "Hyper-IgD syndrome" or "mevalonate kinase deficiency": an old syndrome needing a new name?
    Celsi F; Tommasini A; Crovella S
    Rheumatol Int; 2014 Mar; 34(3):423-4. PubMed ID: 23412692
    [No Abstract]   [Full Text] [Related]  

  • 10. Mevalonate kinase deficiency presenting as recurrent rectal abscesses and perianal fistulae.
    Dunn K; Pasternak B; Kelsen JR; Sullivan KE; Dawany N; Wright BL
    Ann Allergy Asthma Immunol; 2018 Feb; 120(2):214-215. PubMed ID: 29290516
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyper-immunoglobulin D syndrome with novel mutations in an afebrile infant.
    Cadmus SD; Green R; Carrasco R; Levy ML; Diaz LZ
    Pediatr Dermatol; 2018 Jul; 35(4):482-485. PubMed ID: 29600537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A restrospective survey of patients's journey before the diagnosis of mevalonate kinase deficiency.
    Berody S; Galeotti C; Koné-Paut I; Piram M
    Joint Bone Spine; 2015 Jul; 82(4):240-4. PubMed ID: 25677409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome.
    Ammouri W; Cuisset L; Rouaghe S; Rolland MO; Delpech M; Grateau G; Ravet N
    Rheumatology (Oxford); 2007 Oct; 46(10):1597-600. PubMed ID: 17804452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous manifestations in mevalonate kinase deficient patients treated with canakinumab.
    Conte M; Pastore S; Berti I; Taddio A; Tommasini A
    Clin Exp Rheumatol; 2020; 38(4):760-762. PubMed ID: 32324125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mevalonate kinase genotype in children with recurrent fevers and high serum IgD level.
    Stabile A; Compagnone A; Napodano S; Raffaele CG; Patti M; Rigante D
    Rheumatol Int; 2013 Dec; 33(12):3039-42. PubMed ID: 23239036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperimmunoglobulinemia D and periodic fever syndrome].
    Agbo-kpati KP; Condor R; Hollenberg H; Chalvon Demersay A; Cuisset L; Quartier P
    Arch Pediatr; 2014 Jul; 21(7):765-7. PubMed ID: 24935455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome.
    Di Gangi M; Amato G; Converso G; Benenati A; Leonetti C; Borella E; Doria A; Foti R
    Isr Med Assoc J; 2014 Oct; 16(10):605-7. PubMed ID: 25438442
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperimmunoglobulinemia D and periodic fever syndrome].
    Sakai H; Heike T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):382-7. PubMed ID: 22041426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National survey of Japanese patients with mevalonate kinase deficiency reveals distinctive genetic and clinical characteristics.
    Tanaka T; Yoshioka K; Nishikomori R; Sakai H; Abe J; Yamashita Y; Hiramoto R; Morimoto A; Ishii E; Arakawa H; Kaneko U; Ohshima Y; Okamoto N; Ohara O; Hata I; Shigematsu Y; Kawai T; Yasumi T; Heike T
    Mod Rheumatol; 2019 Jan; 29(1):181-187. PubMed ID: 29451047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevalonic Aciduria Associated With Intrahepatic Bile Duct Paucity.
    Chiu M; Garabon J; Chen L; Karp N; Kapoor A; Woolfson JP
    Hepatology; 2021 Sep; 74(3):1702-1704. PubMed ID: 33638873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.